🇺🇸 Rhythm Pharmaceuticals, Inc.
Forum topic · RYTM · Company page: financials, ownership and filings
Join the discussion on Rhythm Pharmaceuticals, Inc.
Loading…
Results announced on 3 November 2026
Rhythm Pharmaceuticals, Inc. announced results on 3 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $92 million (up 80% from a year earlier) and a net loss of $41 million.
Mutual funds: 280 funds hold $3.1 billion
280 mutual funds in 2 countries hold shares of Rhythm Pharmaceuticals, Inc. worth $3.1 billion, about 43.0% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 169 funds added shares and 94 sold; on balance they bought $312 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.